Alerts will be sent to your verified email
Verify EmailPOLSON
|
Polson
|
AG Ventures
|
Par Drugs & Chem.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.26 % | 8.45 % | 16.79 % |
|
5yr average Equity Multiplier
|
1.58 | 1.44 | 1.28 |
|
5yr Average Asset Turnover Ratio
|
0.5 | 0.4 | 0.92 |
|
5yr Avg Net Profit Margin
|
6.56 % | 22.03 % | 14.32 % |
|
Price to Book
|
1.06 | 0.5 | 1.2 |
|
P/E
|
26.84 | 12.85 | 13.21 |
|
5yr Avg Cash Conversion Cycle
|
31.08 Days | 26.6 Days | -12.24 Days |
|
Inventory Days
|
77.75 Days | 72.77 Days | 16.4 Days |
|
Days Receivable
|
50.55 Days | 22.55 Days | 48.97 Days |
|
Days Payable
|
97.28 Days | 80.97 Days | 90.62 Days |
|
5yr Average Interest Coverage Ratio
|
2.7 | 39.08 | 113.93 |
|
5yr Avg ROCE
|
8.44 % | 8.49 % | 20.52 % |
|
5yr Avg Operating Profit Margin
|
16.59 % | 21.6 % | 22.04 % |
|
5 yr average Debt to Equity
|
0.41 | 0.19 | 0.03 |
|
5yr CAGR Net Profit
|
-9.32 % | -33.25 % | 2.85 % |
|
5yr Average Return on Assets
|
3.31 % | 5.78 % | 13.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.98 % | 51.76 % | 73.37 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.84 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -8.4 % | 0.0 |
|
Polson
|
AG Ventures
|
Par Drugs & Chem.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|